| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |